BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jernigan PL, Wima K, Hanseman DJ, Hoehn RS, Ahmad SA, Shah SA, Abbott DE. Natural history and treatment trends in hepatocellular carcinoma subtypes: Insights from a national cancer registry: HCC Subtypes. J Surg Oncol 2015;112:872-6. [DOI: 10.1002/jso.24083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Wu L, Tsilimigras DI, Farooq A, Hyer JM, Merath K, Paredes AZ, Mehta R, Sahara K, Shen F, Pawlik TM. Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: A population-based analysis. Cancer 2019;125:3767-75. [PMID: 31299092 DOI: 10.1002/cncr.32396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
2 Liao SH, Su TH, Jeng YM, Liang PC, Chen DS, Chen CH, Kao JH. Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma. Hepatology 2019;69:209-21. [PMID: 30014620 DOI: 10.1002/hep.30162] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
3 Ramai D, Ofosu A, Lai JK, Gao ZH, Adler DG. Fibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study. Dig Dis Sci 2021;66:308-14. [PMID: 32052215 DOI: 10.1007/s10620-020-06135-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Nautsch F, Ludwig JM, Xing M, Johnson KM, Kim HS. Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population Study. Journal of Clinical Gastroenterology 2018;52:262-7. [DOI: 10.1097/mcg.0000000000000833] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
5 Cha HS, Jung JM, Shin SY, Jang YM, Park P, Lee JW, Chung SH, Choi KS. The Korea Cancer Big Data Platform (K-CBP) for Cancer Research. Int J Environ Res Public Health 2019;16:E2290. [PMID: 31261630 DOI: 10.3390/ijerph16132290] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
6 Chen X, Lu Y, Shi X, Han G, Zhang L, Ni C, Zhao J, Gao Y, Wang X. Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma. Front Oncol 2022;12:864106. [DOI: 10.3389/fonc.2022.864106] [Reference Citation Analysis]
7 Farooq A, Merath K, Paredes AZ, Wu L, Tsilimigras DI, Hyer JM, Sahara K, Mehta R, Beal EW, Pawlik TM. Outcomes of Patients with Scirrhous Hepatocellular Carcinoma: Insights from the National Cancer Database. J Gastrointest Surg 2020;24:1049-60. [PMID: 31243715 DOI: 10.1007/s11605-019-04282-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Vyas M, Zhang X. Hepatocellular Carcinoma. Clinics in Liver Disease 2020;24:591-610. [DOI: 10.1016/j.cld.2020.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang Z, Xie H, Chen P, Cao P. Development and Identification of a Nomogram Prognostic Model for Patients with Primary Clear Cell Carcinoma of the Liver. Med Sci Monit 2020;26:e919789. [PMID: 31969554 DOI: 10.12659/MSM.919789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Tefera J, Revzin M, Chapiro J, Savic LJ, Mulligan D, Batra R, Taddei T, Jain D, Zhang X. Fibronodular hepatocellular carcinoma-a new variant of liver cancer: clinical, pathological and radiological correlation. J Clin Pathol. 2021;74:31-35. [PMID: 32430483 DOI: 10.1136/jclinpath-2020-206574] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Ji W, Xing Y, Ma J, Zhao Z, Xu H, Zheng S, Li W, Li X. Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review. J Hepatocell Carcinoma 2021;8:1117-27. [PMID: 34522692 DOI: 10.2147/JHC.S325182] [Reference Citation Analysis]
12 Zakka K, Jiang R, Alese OB, Shaib WL, Wu C, Wedd JP, Sellers MT, Behera M, El-Rayes BF, Akce M. Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma. J Hepatocell Carcinoma 2019;6:119-29. [PMID: 31413960 DOI: 10.2147/JHC.S215235] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
13 Numbere N, Zhang D, Agostini-Vulaj D. A rare histologic subtype of hepatocellular carcinoma, sarcomatoid hepatocellular carcinoma: report of a case. Hepat Oncol 2020;8:HEP33. [PMID: 34084452 DOI: 10.2217/hep-2020-0027] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Li Z, Wu X, Bi X, Zhang Y, Huang Z, Lu H, Zhao H, Zhao J, Zhou J, Li M, Ying J, Cai J. Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma. Chin J Cancer Res 2018;30:364-72. [PMID: 30046230 DOI: 10.21147/j.issn.1000-9604.2018.03.08] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
15 Espinosa JA, Merlo A Jr, Arafeh MO, Munene G. An unusual case of jaundice: Biliary tumor thrombus in fibrolamellar hepatocellular carcinoma. Int J Surg Case Rep 2017;36:50-4. [PMID: 28531870 DOI: 10.1016/j.ijscr.2017.03.039] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Chakrabarti S, Tella SH, Kommalapati A, Huffman BM, Yadav S, Riaz IB, Goyal G, Mody K, Borad M, Cleary S, Smoot RL, Mahipal A. Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma. J Gastrointest Oncol 2019;10:554-61. [PMID: 31183207 DOI: 10.21037/jgo.2019.01.35] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]